发明授权
US07217713B2 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
有权
HIV整合酶的N-取代羟基嘧啶酮羧酰胺抑制剂
- 专利标题: N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
- 专利标题(中): HIV整合酶的N-取代羟基嘧啶酮羧酰胺抑制剂
-
申请号: US11491815申请日: 2006-07-24
-
公开(公告)号: US07217713B2公开(公告)日: 2007-05-15
- 发明人: Benedetta Crescenzi , Cristina Gardelli , Ester Muraglia , Emanuela Nizi , Federica Orvieto , Paola Pace , Giovanna Pescatore , Alessia Petrocchi , Marco Poma , Michael Rowley , Rita Scarpelli , Vincenzo Summa
- 申请人: Benedetta Crescenzi , Cristina Gardelli , Ester Muraglia , Emanuela Nizi , Federica Orvieto , Paola Pace , Giovanna Pescatore , Alessia Petrocchi , Marco Poma , Michael Rowley , Rita Scarpelli , Vincenzo Summa
- 申请人地址: IT Pomezia (Rome)
- 专利权人: Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.p.A.
- 当前专利权人: Istituto Di Richerche Di Biologia Molecolare P. Angeletti S.p.A.
- 当前专利权人地址: IT Pomezia (Rome)
- 代理商 Kenneth R. Walton; Valerie J. Camara
- 主分类号: A61K31/515
- IPC分类号: A61K31/515 ; C07D239/54
摘要:
N-substituted 5-hydroxypyrimidin-6-one-4-carboxamides of formula: are described as inhibitors of HIV integrase and inhibitors of HIV replication, wherein R1, R2, R3 and R4 are defined herein. These compounds are useful in the prevention and treatment of infection by HIV and in the prevention, delay in the onset, and treatment of AIDS. The compounds-are employed against HIV infection and AIDS as compounds per se or in the form of pharmaceutically acceptable salts. The compounds and their salts can be employed as ingredients in pharmaceutical compositions, optionally in combination with other antivirals, immunomodulators, antibiotics or vaccines. Methods of preventing, treating or delaying the onset of AIDS and methods of preventing or treating infection by HIV are also described.
公开/授权文献
信息查询
IPC分类: